Evidence map›Paper›PMID 31908526›Full record

ArticleCancer management and research2019

GALE Promotes the Proliferation and Migration of Glioblastoma Cells and Is Regulated by miR-let-7i-5p.

Xiaopeng Sun, Hao Xue, Ye Xiong, Rui Yu, Xiao Gao, Mingyu Qian, Shaobo Wang, Huizhi Wang, Jianye Xu, Zihang Chen and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cancer management and research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Therapeutic Applications of Poly-miRNAs and miRNA Sponges.International journal of molecular sciences · 2025
    Review
  4. LetZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2023
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Xiaopeng SunDepartment of Neurosurgery, Qilu Hospital of Shandong University, Jinan, Shandong Province 250012, People's Republic of China.ORCID 0000-0002-4092-0413
Hao XueDepartment of Neurosurgery, Qilu Hospital of Shandong University, Jinan, Shandong Province 250012, People's Republic of China.
Ye XiongDepartment of Neurosurgery, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province 325000, People's Republic of China.
Rui YuDepartment of Neurosurgery, The Second Hospital of Shandong University, Jinan 250033, People's Republic of China.
Xiao GaoDepartment of Neurosurgery, Qilu Hospital of Shandong University, Jinan, Shandong Province 250012, People's Republic of China.
Mingyu QianDepartment of Neurosurgery, Qilu Hospital of Shandong University, Jinan, Shandong Province 250012, People's Republic of China.
Shaobo WangDepartment of Neurosurgery, Qilu Hospital of Shandong University, Jinan, Shandong Province 250012, People's Republic of China.
Huizhi WangDepartment of Neurosurgery, Qilu Hospital of Shandong University, Jinan, Shandong Province 250012, People's Republic of China.
Jianye XuDepartment of Neurosurgery, Qilu Hospital of Shandong University, Jinan, Shandong Province 250012, People's Republic of China.ORCID 0000-0001-7241-6994
Zihang ChenDepartment of Neurosurgery, Qilu Hospital of Shandong University, Jinan, Shandong Province 250012, People's Republic of China.ORCID 0000-0001-8392-3473
Lin DengDepartment of Neurosurgery, Qilu Hospital of Shandong University, Jinan, Shandong Province 250012, People's Republic of China.
Gang LiDepartment of Neurosurgery, Qilu Hospital of Shandong University, Jinan, Shandong Province 250012, People's Republic of China.
Qilu Hospital of Shandong University · CNShandong University · CNSecond Hospital of Shandong University · CNWenzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeGlioma is the most common and lethal type of brain tumor. While GALE (UDP-galactose-4-epimerase) has been shown to be overexpressed in some kinds of cancers, its expression in gliomas has not been reported. MicroRNAs (miRNAs) function as tumor suppressors in many cancers, and online datasets can be used to predict whether GALE is regulated by miR-let-7i-5p. In this investigation, we explored the effect and regulatory mechanisms of GALE on glioblastoma growth via miR-let-7i-5p.

methodsWe used a Cox proportional hazards model and publicly available datasets to examine the relationship between GALE and the survival rates of glioma patients. Bioinformatics predicted the targeting of GALE by miR-let-7i-5p. The proliferation, migration, cell cycle and apoptosis of human glioblastoma cells were assessed by relevant assays. We also demonstrated the effect of GALE on glioblastoma multiforme [GBM] tumor growth using an in vivo orthotopic xenograft model.

resultsGALE was upregulated in human gliomas, especially in high-grade gliomas (e.g., GBM). An obvious decline in GALE expression was observed in human glioblastoma cell lines (U87 and U251) following treatment with a small interfering RNA (siRNA) targeting GALE or miR-let-7i-5p mimics. Knockdown of GALE or overexpression of miR-let-7i-5p (with miR-let-7i-5p mimics) inhibited U87 and U251 cell growth. miR-let-7i-5p significantly restrained the migration ability of human glioblastoma cells in vascular mimic (VM), wound healing and transwell assays, and GALE promoted glioblastoma growth in vivo.

conclusionOur findings confirm that GALE plays an important role in promoting the development of human glioma and that GALE can be regulated by miR-let-7i-5p to inhibit human glioblastoma growth. IMPLICATIONS FOR CANCER SURVIVORS: Our data show that cancer survivors have low GALE expression, which indicates that GALE may be a diagnostic biomarker and a promising therapeutic target in glioblastoma.

Indexed as

GALEglioblastomamigrationmiR-let-7i-5pproliferation

Identifiers

PMID31908526
PMCPMC6924591
OpenAlexW2996721422

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.